Your browser doesn't support javascript.
loading
Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission.
Pagani, Ilaria S; Dang, Phuong; Saunders, Verity A; Grose, Randall; Shanmuganathan, Naranie; Kok, Chung H; Carne, Lisa; Rwodzi, Zandy; Watts, Sophie; McLean, Jennifer; Braley, Jodi; Altamura, Haley; Yeung, David T; Branford, Susan; Yong, Agnes S M; White, Deborah L; Hughes, Timothy P; Ross, David M.
Afiliación
  • Pagani IS; Cancer Program, Precision Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia.
  • Dang P; School of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.
  • Saunders VA; Australasian Leukaemia and Lymphoma Group, Melbourne, VIC, Australia.
  • Grose R; Cancer Program, Precision Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia.
  • Shanmuganathan N; Cancer Program, Precision Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia.
  • Kok CH; Cancer Program, Precision Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia.
  • Carne L; Cancer Program, Precision Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia.
  • Rwodzi Z; School of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.
  • Watts S; Australasian Leukaemia and Lymphoma Group, Melbourne, VIC, Australia.
  • McLean J; Department of Haematology and Bone Marrow Transplantation, Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Braley J; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.
  • Altamura H; Genetic and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
  • Yeung DT; Cancer Program, Precision Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia.
  • Branford S; School of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.
  • Yong ASM; Department of Haematology and Bone Marrow Transplantation, Royal Adelaide Hospital, Adelaide, SA, Australia.
  • White DL; Department of Haematology and Bone Marrow Transplantation, Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Hughes TP; Cancer Program, Precision Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia.
  • Ross DM; Cancer Program, Precision Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia.
Leukemia ; 34(4): 1052-1061, 2020 04.
Article en En | MEDLINE | ID: mdl-31768016
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Subgrupos Linfocitarios / Proteínas de Fusión bcr-abl / Neoplasia Residual / Linaje de la Célula / Mesilato de Imatinib Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Subgrupos Linfocitarios / Proteínas de Fusión bcr-abl / Neoplasia Residual / Linaje de la Célula / Mesilato de Imatinib Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Australia